Harald Illges

2.1k total citations
57 papers, 1.4k citations indexed

About

Harald Illges is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Harald Illges has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 19 papers in Molecular Biology and 12 papers in Hematology. Recurrent topics in Harald Illges's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (11 papers) and Complement system in diseases (8 papers). Harald Illges is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (11 papers) and Complement system in diseases (8 papers). Harald Illges collaborates with scholars based in Germany, Switzerland and United States. Harald Illges's co-authors include Madhan Masilamani, Samuel G. Solomon, Michael Schlesier, Hermann Eibel, Hans‐Hartmut Peter, Narendiran Rajasekaran, Lawrence Rajendran, Eva‐Maria Boneberg, Klaus Warnatz and Claudia Wehr and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Harald Illges

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald Illges Germany 21 772 479 228 224 157 57 1.4k
Sara J. Piddlesden United Kingdom 21 1.1k 1.5× 424 0.9× 278 1.2× 249 1.1× 54 0.3× 30 2.2k
Beren H. Tomooka United States 15 410 0.5× 556 1.2× 573 2.5× 454 2.0× 72 0.5× 17 1.4k
Yoshihiro Fukuoka Japan 22 824 1.1× 434 0.9× 148 0.6× 112 0.5× 79 0.5× 63 1.4k
Frank C. Stomski Australia 23 800 1.0× 727 1.5× 89 0.4× 139 0.6× 103 0.7× 35 1.8k
Minghua Zhu United States 24 1.1k 1.4× 675 1.4× 54 0.2× 122 0.5× 85 0.5× 66 1.9k
Fei-Hua Qiu United States 9 607 0.8× 685 1.4× 55 0.2× 143 0.6× 139 0.9× 13 1.5k
Katalin Kis‐Tóth United States 26 1.1k 1.4× 492 1.0× 662 2.9× 121 0.5× 39 0.2× 51 1.7k
Marcin P. Mycko Poland 24 801 1.0× 908 1.9× 133 0.6× 55 0.2× 68 0.4× 52 1.9k
J. Christopher Grimaldi United States 16 1.1k 1.4× 551 1.2× 71 0.3× 105 0.5× 101 0.6× 19 2.5k
Arthur H. Tatum United States 24 298 0.4× 433 0.9× 115 0.5× 247 1.1× 89 0.6× 50 1.7k

Countries citing papers authored by Harald Illges

Since Specialization
Citations

This map shows the geographic impact of Harald Illges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Illges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Illges more than expected).

Fields of papers citing papers by Harald Illges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Illges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Illges. The network helps show where Harald Illges may publish in the future.

Co-authorship network of co-authors of Harald Illges

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Illges. A scholar is included among the top collaborators of Harald Illges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Illges. Harald Illges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Opuni, Kwabena F.M., et al.. (2019). Intact Transition Epitope Mapping – Targeted High-Energy Rupture of Extracted Epitopes (ITEM-THREE)*. Molecular & Cellular Proteomics. 18(8). 1543–1555. 19 indexed citations
2.
Häußler, Susanne, et al.. (2012). A Monoclonal Antibody Against Bovine Adiponectin. Hybridoma. 31(6). 465–468. 5 indexed citations
3.
Schmidt‐Wolf, Ingo G.H., et al.. (2012). Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression. International Journal of Hematology. 96(3). 350–356. 3 indexed citations
4.
Rasmussen, Susanne, Jeppe Madura Larsen, Cathrine Ørskov, et al.. (2011). JNK1, but Not JNK2, Is Required in Two Mechanistically Distinct Models of Inflammatory Arthritis. American Journal Of Pathology. 179(4). 1884–1893. 16 indexed citations
5.
Illges, Harald, et al.. (2011). Maximal locomotor depression follows maximal ankle swelling during the progression of arthritis in K/BxN mice. Rheumatology International. 32(12). 3999–4003. 6 indexed citations
6.
Rajasekaran, Narendiran, Samuel G. Solomon, Takeshi Watanabe, et al.. (2009). Histidine decarboxylase but not histamine receptor 1 or 2 deficiency protects from K/BxN serum-induced arthritis. International Immunology. 21(11). 1263–1268. 11 indexed citations
7.
Rajendran, Lawrence, Julia Beckmann, Astrid Magenau, et al.. (2009). Flotillins Are Involved in the Polarization of Primitive and Mature Hematopoietic Cells. PLoS ONE. 4(12). e8290–e8290. 35 indexed citations
8.
9.
Masilamani, Madhan, Narendiran Rajasekaran, Kerstin Albus, et al.. (2008). Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease. Rheumatology International. 28(11). 1137–1141. 1 indexed citations
10.
Rajendran, Lawrence, Soazig Le Lay, & Harald Illges. (2007). Raft association and lipid droplet targeting of flotillins are independent of caveolin. Biological Chemistry. 388(3). 307–14. 40 indexed citations
11.
Solomon, Samuel G., Daniela Kassahn, & Harald Illges. (2005). The role of the complement and the Fc gamma R system in the pathogenesis of arthritis.. Arthritis Research & Therapy. 7(4). 129–129. 34 indexed citations
12.
Möller, Steffen, Eilhard Mix, Martin Blüggel, et al.. (2005). Collection of Soluble Variants of Membrane Proteins for Transcriptomics and Proteomics. In Silico Biology. 5(3). 295–311. 3 indexed citations
13.
Masilamani, Madhan, Torsten Witte, Michael Schlesier, et al.. (2004). Reduction of Soluble Complement Receptor 2/CD21 in Systemic Lupus Erythomatosus and Sjögren's Syndrome but not Juvenile Arthritis. Scandinavian Journal of Immunology. 60(6). 625–630. 23 indexed citations
14.
Boneberg, E-M, et al.. (2004). Hydrostatic Pressure Induces Apoptosis in the Human Leukaemic T‐Cell Line Jurkat Via the Mitochondrial Pathway. Scandinavian Journal of Immunology. 60(4). 403–411. 1 indexed citations
15.
Masilamani, Madhan, Daniela Kassahn, Stefan Mikkat, Michael O. Glocker, & Harald Illges. (2003). B cell activation leads to shedding of complement receptor type II (CR2/CD21). European Journal of Immunology. 33(9). 2391–2397. 47 indexed citations
16.
Masilamani, Madhan, Hans‐Jürgen Apell, & Harald Illges. (2002). Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation. Journal of Immunological Methods. 270(1). 11–18. 13 indexed citations
17.
Shen, Hua, Harald Illges, Alexander Reuter, & Claudia A. O. Stuermer. (2002). Cloning, expression, and alternative splicing of neogenin1 in zebrafish. Mechanisms of Development. 118(1-2). 219–223. 19 indexed citations
18.
Illges, Harald, et al.. (2001). Regulation of CD21 expression by DNA methylation and histone deacetylation. International Immunology. 13(5). 705–710. 28 indexed citations
19.
Denz, Axel, Hermann Eibel, Harald Illges, et al.. (2000). Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients. European Journal of Immunology. 30(4). 1069–1077. 38 indexed citations
20.
Lassoued, Kaı̈ss, Harald Illges, Kamel Benlagha, & M D Cooper. (1996). Fate of surrogate light chains in B lineage cells.. The Journal of Experimental Medicine. 183(2). 421–429. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara J. Piddlesden Breakdown of academic impact, for papers by Beren H. Tomooka Breakdown of academic impact, for papers by Yoshihiro Fukuoka Breakdown of academic impact, for papers by Frank C. Stomski Breakdown of academic impact, for papers by Minghua Zhu Breakdown of academic impact, for papers by Fei-Hua Qiu Breakdown of academic impact, for papers by Katalin Kis‐Tóth Breakdown of academic impact, for papers by Marcin P. Mycko Breakdown of academic impact, for papers by J. Christopher Grimaldi Breakdown of academic impact, for papers by Arthur H. Tatum
Rankless by CCL
2026